Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.3420
-0.0580 (-14.50%)
At close: Dec 18, 2025, 4:00 PM EST
0.2751
-0.0669 (-19.56%)
After-hours: Dec 18, 2025, 7:47 PM EST
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $26.93 million as of December 18, 2025. Its market cap has decreased by -63.67% in one year.
Market Cap
26.93M
Enterprise Value
12.68M
1-Year Change
-63.67%
Ranking
Category
Stock Price
$0.34
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $226.28M to $26.93M, a decrease of -88.10%. That is a compound annual growth rate of -23.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 17, 2025 | 31.50M | -54.39% |
| Dec 31, 2024 | 69.05M | -42.03% |
| Dec 29, 2023 | 119.13M | -2.89% |
| Dec 30, 2022 | 122.67M | -65.85% |
| Dec 31, 2021 | 359.22M | -5.17% |
| Dec 31, 2020 | 378.78M | 3.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 932.80B |
| Johnson & Johnson | 506.75B |
| AbbVie | 396.44B |
| UnitedHealth Group | 300.40B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 246.17B |
| Abbott Laboratories | 220.33B |